Response to the ‘Comment on the editorial by Turner : risk assessment vs. risk aversion by Zannad et al.et al.: risk assessment vs. risk aversion by Zannad et al.’ on Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles